Sacituzumab govitecan-hziy Clinical Trials

6 actively recruiting trials across 6 locations

Also known as: GS-0132, IMMU-132, Trodelvy, Trodelvy™

Filter by location:

Tucson, Arizona1 trial

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

The University of Arizona Cancer Center-North Campus

Phase 2

Irvine, California1 trial

Study of DF1001 in Patients with Advanced Solid Tumors

University of California Irvine Medical Center

Phase 1/2

Long Beach, California1 trial

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Pacific Shores Medical Group

Phase 1

Palo Alto, California1 trial

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Stanford Cancer Institute

Phase 2

New Haven, Connecticut1 trial

Study of AVZO-021 in Patients With Advanced Solid Tumors

Yale Cancer Center

Phase 1/2

Basking Ridge, New Jersey1 trial

A Study of Sacituzumab Govitecan in People With Mesothelioma

Memorial Sloan Kettering Basking Ridge

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.